Bank of New York Mellon’s Tyra Biosciences TYRA Stock Holding History

Bank of New York Mellon’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.31M	Buy	103,720 +31,507	+44%	+$1.04M	﹤0.01%	2675
2026 Q1	$2.77M	Buy	72,213 +11,312	+19%	+$366K	﹤0.01%	2650
2025 Q4	$1.6M	Buy	60,901 +3,739	+7%	+$68.7K	﹤0.01%	2969
2025 Q3	$800K	Buy	57,162 +3,123	+6%	+$35.6K	﹤0.01%	3342
2025 Q2	$517K	Buy	54,039 +12,956	+32%	+$123K	﹤0.01%	3487
2025 Q1	$382K	Sell	41,083 -3,924	-9%	-$50.8K	﹤0.01%	3583
2024 Q4	$626K	Buy	45,007 +2,221	+5%	+$40.3K	﹤0.01%	3402
2024 Q3	$1.01M	Sell	42,786 -15,301	-26%	-$321K	﹤0.01%	3137
2024 Q2	$929K	Buy	58,087 +14,352	+33%	+$247K	﹤0.01%	3247
2024 Q1	$717K	Buy	43,735 +1,790	+4%	+$29.4K	﹤0.01%	3323
2023 Q4	$581K	Buy	41,945 +75	+0.2%	+$971	﹤0.01%	3472
2023 Q3	$577K	Buy	41,870 +1,074	+3%	+$15.9K	﹤0.01%	3470
2023 Q2	$695K	Sell	40,796 -735	-2%	-$10.7K	﹤0.01%	3416
2023 Q1	$667K	Sell	41,531 -4,838	-10%	-$57.5K	﹤0.01%	3336
2022 Q4	$352K	Buy	46,369 +7,119	+18%	+$50.3K	﹤0.01%	3721
2022 Q3	$345K	Buy	39,250 +7,339	+23%	+$67.1K	﹤0.01%	3762
2022 Q2	$228K	Buy	31,911 +1,291	+4%	+$10.3K	﹤0.01%	4006
2022 Q1	$328K	Buy	30,620 +10,045	+49%	+$119K	﹤0.01%	3968
2021 Q4	$289K	Buy	+20,575	New	+$409K	﹤0.01%	4107

Other funds holding TYRA

APMC

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CPX

Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Bank of New York Mellon's TYRA Position: Q2 2026 in Review

Bank of New York Mellon increased its Tyra Biosciences (TYRA) stake by 44% in Q2 2026, buying an estimated $1.04M and bringing the position to 103,720 shares worth $3.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2675.

Bank of New York Mellon first reported a position in TYRA in Q4 2021 and has held it in 19 quarters since. 63 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

Bank of New York Mellon held 103,720 shares of Tyra Biosciences worth $3.31M as of Q2 2026.
Bank of New York Mellon bought 31,507 Tyra Biosciences shares in Q2 2026, an estimated $1.04M.
Tyra Biosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2675 holding.
Bank of New York Mellon first reported a position in Tyra Biosciences in Q4 2021 and has held it in 19 quarters since.
63 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.